Contract Processing of Protective Clothing and Face Shields Related to COVID-19
First written in FY2021-Q2. 2 of 5 entries say "Restated". Latest entry: FY2022-Q3.
0 other companies' latest entry also says "Other".
- FY2022-Q3Lower sales due to the absence of public tenders for protective clothing coexist with higher profits from higher-priced poultice productsAnnual report
「Sales declined because no public tender was held for protective clothing related to COVID-19. In the patch products business, sales were affected by the discontinuation of products adopted by customers and a temporary decline resulting from a review of the product mix for release films, bringing net sales to ¥1,006 million, down 15.5% year on year. Gross profit increased 11.7% year on year to ¥231 million, due to strong performance in relatively high-priced patch products.」
Although the medical and pharmaceutical businesses recorded lower sales due to the absence of public tenders for protective clothing and the discontinuation of adopted products, gross profit increased on strong sales of high-priced patch products. - FY2022-Q2WorsenedAnnual report
「Sales declined because protective clothing was still not subject to a public tender related to COVID-19, resulting in delays in bidding.」
The previously reported contract processing related to the infectious disease was described as having declined in the protective-clothing area because no public tender had been held and bidding had been delayed. - FY2021RestatedAnnual report
「We undertook contract processing of protective clothing, face shields and other products related to COVID-19.」
Contract processing of protective clothing and face shields related to the infectious disease continues to be listed as a track record in the medical and pharmaceutical businesses. - FY2021-Q3RestatedAnnual report
「We undertook contract processing of protective clothing, face shields and other products related to COVID-19.」
Contract processing of protective clothing and face shields related to the infectious disease continues to be listed as a track record in the medical and pharmaceutical businesses. - FY2021-Q2First statedAnnual report
「We undertook contract processing of protective clothing, face shields and other products related to COVID-19.」
For the first time, contract processing of protective clothing and face shields related to COVID-19 was listed as a new track record in the medical and pharmaceutical businesses.